Inhaled antibiotic for drug-resistant pneumonia after stroke
Part of Infections, Lungs & breathing clinical trials.
This study tests whether adding an inhaled antibiotic (polymyxin) to standard IV antibiotics helps treat a severe lung infection that is resistant to many drugs. It is for people who had a stroke and developed this infection while on a breathing machine. The inhaled drug is delivered directly to the lungs, which might improve treatment and reduce side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult who had a stroke confirmed by a CT or MRI scan.
- You must be diagnosed with pneumonia caused by multidrug-resistant bacteria.
- You must be stable enough to take part and be receiving IV antibiotics.
- You need to be willing to give consent (or a legal guardian can).
- You cannot be allergic to colistin, pregnant, have severe kidney disease, or have a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving an inhaled antibiotic called colistin can prevent pneumonia in patients with brain injuries who are on ventilators. If effective, it could reduce lung infections and improve recovery.
This trial tests if inhaling a medication called colistin can prevent ventilator-associated pneumonia (a lung infection) in patients who are on a breathing machine. It aims to reduce the risk for those at high risk of getting an infection from drug-resistant bacteria.
This trial tests whether inhaling an antibiotic called amikacin can prevent ventilator-associated pneumonia in patients with severe liver disease (cirrhosis) who are on a breathing machine. If you or your loved one is in the ICU with liver issues and needs a ventilator, this study may help reduce the risk of a serious lung infection.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
This trial tests whether using a rapid test to find the exact bacteria causing your pneumonia can help doctors choose the right antibiotics faster, which might improve your recovery. The study compares this approach to usual care in patients on ventilators.
This trial tests if giving a medication (colistin) both through an IV and as a mist you breathe in works better for lung infections caused by bacteria that are hard to treat with standard antibiotics. It may help patients who have these tough bacteria and are in the hospital.
Hear when a new Ventilator Associated Pneumonia ( VAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.